1. Date of AGM: 115/05/29. 2. Resolution 1: Approval of the 114th fiscal year earnings distribution, with a total cash dividend of 6,782,003 NTD, or 0.112 NTD per share. 3. Resolution 2: No amendments to the Articles of Incorporation. 4. Resolution 3: Approval of the 114th fiscal year business report and financial statements. 5. Resolution 4: Election of 7 directors for the 10th board (including 3 independent directors), term 3 years. 6. Resolution 5: Approval of amendments to asset acquisition/disposal procedures and lifting of non-compete restrictions for new directors. 7. Other: None.
FACT BOX
- Source: PR Times
- Category: AGM Resolution
- Organizations: Medigen Biotechnology
- Dates in source: 115/05/29